iRhythm Technologies, Inc. is a digital healthcare company focused on the advancement of cardiac care. Founded in 2006, iRhythm is dedicated to the development of innovative technologies that provide superior data, analytics, and insights for the diagnosis and management of cardiac arrhythmias. The company’s flagship product, the Zio service, offers a comprehensive ambulatory cardiac monitoring solution that has transformed the way arrhythmias are detected and diagnosed. iRhythm’s proprietary platform combines wearable biosensing technology with cloud-based data analytics and machine learning to deliver clinically actionable information to physicians. This enables more personalized and effective patient care. With a commitment to improving patient outcomes, iRhythm collaborates with healthcare providers, payers, and patients to ensure access to its advanced monitoring solutions. The company’s mission is to become the leading provider of ambulatory ECG monitoring for patients at risk for arrhythmias. iRhythm’s innovative approach to cardiac monitoring has earned it recognition as a pioneer in the field of digital health, with its technologies being used by thousands of healthcare providers across the United States and internationally. By leveraging the power of data and technology, iRhythm is setting new standards in cardiac care and making a meaningful difference in the lives of patients with heart rhythm disorders.